During the past decade, Städtisches Klinikum Karlsruhe conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 13 clinical trials were completed, i.e. on average, 28.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 9 clinical trials were completed. i.e. 56.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Städtisches Klinikum Karlsruhe" #1 sponsor was "University of Ulm" with 11 trials, followed by "German CLL Study Group" with 8 trials sponsored, "Boston Scientific Corporation" with 6 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored and "Universitätsklinikum Hamburg-Eppendorf" with 5 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Städtisches Klinikum Karlsruhe" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 3 trials as a collaborator, "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Hannover Medical School" with 3 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator and "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator. Other collaborators include 103 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Städtisches Klinikum Karlsruhe" are "Acute Myeloid Leukemia" (8 trials), "Chronic Lymphocytic Leukemia" (8 trials), "Lymphoma" (8 trials), "Leukemia" (7 trials) and "Atrial Fibrillation" (6 trials). Many other conditions were trialed in "Städtisches Klinikum Karlsruhe" in a lesser frequency.

Most popular intervention types in "Städtisches Klinikum Karlsruhe" are "Drug" (56 trials), "Procedure" (21 trials), "Device" (19 trials), "Biological" (18 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (12 trials), "radiation therapy" (10 trials), "filgrastim" (9 trials), "vincristine sulfate" (9 trials) and "Cytarabine" (8 trials). Other intervention names were less common.

The vast majority of trials in "Städtisches Klinikum Karlsruhe" are 93 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Städtisches Klinikum Karlsruhe". undefined are not yet recruiting, 18 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Städtisches Klinikum Karlsruhe, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Städtisches Klinikum Karlsruhe, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".

Städtisches Klinikum Karlsruhe has several departments that took part in Clinical trials: "Medical Department II, City Hospital Karlsruhe gGmbH" - 4 trials, "Städtisches Klinikum Karlsruhe gGmbH, Kinderklinik, Station S 24" - 2 trials